Vaccinia virus injected human tumors: oncolytic virus efficiency predicted by antigen profiling analysis fitted boolean models

Virotherapy on the basis of oncolytic vaccinia virus (VACV) strains is a promising approach for cancer therapy. Recently, we showed that the oncolytic vaccinia virus GLV-1h68 has a therapeutic potential in treating human prostate and hepatocellular carcinomas in xenografted mice. In this study, we d...

Descripción completa

Detalles Bibliográficos
Autores principales: Cecil, Alexander, Gentschev, Ivaylo, Adelfinger, Marion, Dandekar, Thomas, Szalay, Aladar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550548/
https://www.ncbi.nlm.nih.gov/pubmed/31142183
http://dx.doi.org/10.1080/21655979.2019.1622220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550548/
https://www.ncbi.nlm.nih.gov/pubmed/31142183
http://dx.doi.org/10.1080/21655979.2019.1622220

Ejemplares similares